GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
$1.15
-0.0200 (-1.71%)
At Close: Apr 19, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $1.05 $2.79 Friday, 19th Apr 2024 FGEN stock ended at $1.15. This is 1.71% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 12.38% from a day low at $1.05 to a day high of $1.18.
90 days $0.775 $2.93
52 weeks $0.335 $20.44

Historical FibroGen prices

Date Open High Low Close Volume
2023-11-24 $0.489 $0.520 $0.480 $0.485 363 294
2023-11-22 $0.491 $0.514 $0.470 $0.478 554 890
2023-11-21 $0.550 $0.550 $0.480 $0.489 606 681
2023-11-20 $0.553 $0.630 $0.524 $0.529 1 157 209
2023-11-17 $0.512 $0.574 $0.500 $0.571 1 706 051
2023-11-16 $0.520 $0.530 $0.460 $0.500 1 434 642
2023-11-15 $0.470 $0.539 $0.462 $0.511 2 295 107
2023-11-14 $0.416 $0.489 $0.400 $0.481 3 031 760
2023-11-13 $0.374 $0.430 $0.345 $0.415 5 221 931
2023-11-10 $0.390 $0.395 $0.335 $0.380 5 195 694
2023-11-09 $0.475 $0.486 $0.390 $0.390 4 742 600
2023-11-08 $0.567 $0.567 $0.460 $0.476 2 657 285
2023-11-07 $0.640 $0.710 $0.536 $0.552 2 696 224
2023-11-06 $0.694 $0.694 $0.557 $0.559 2 160 162
2023-11-03 $0.588 $0.658 $0.570 $0.647 2 713 252
2023-11-02 $0.541 $0.585 $0.530 $0.567 1 424 137
2023-11-01 $0.550 $0.563 $0.510 $0.547 917 286
2023-10-31 $0.510 $0.568 $0.490 $0.541 1 143 529
2023-10-30 $0.480 $0.510 $0.475 $0.502 1 350 124
2023-10-27 $0.535 $0.580 $0.475 $0.476 1 825 976
2023-10-26 $0.518 $0.597 $0.505 $0.535 893 397
2023-10-25 $0.530 $0.550 $0.490 $0.535 1 460 044
2023-10-24 $0.538 $0.543 $0.507 $0.518 1 232 234
2023-10-23 $0.532 $0.550 $0.500 $0.507 1 865 096
2023-10-20 $0.580 $0.615 $0.542 $0.550 1 050 285
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Golden Star

Ticker Date Change Price
DOOR Apr 17 0.0305% $131.35
LNG Apr 17 3.29% $156.81
FCN Apr 16 1.75% $207.62
ELV Apr 16 4.82% $506.97
FTSL Apr 16 0.217% $46.08
AKR Apr 05 3.15% $16.53
ITCI Apr 05 5.74% $68.44
SARK Mar 28 18.79% $26.88
SON Mar 26 0.83% $56.64
ARCC Mar 25 2.34% $20.12
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT